The goal of this T32 program, entitled Research in Alimentary Tract Surgery, is to enhance the professional development and research capabilities of new surgeon-scientists and postgraduate-level PhDs, with a specific interest in academic careers related to the study of digestive disease. This unique program will take advantage of three already-established research focus groups (RFGs) that straddle the Departments of Surgery, Molecular Genetics, Molecular and Cellular Physiology, Pathology and Developmental Biology at the University of Cincinnati College of Medicine and the Cincinnati Children's Hospital Medical Center. These RFGs cover the thematic core areas of Epithelial Pathobiology, GI Oncology, and Adaptation/Developmental Biology. Each RFG is led by an NIH-funded surgeon-scientist in the Department of Surgery as well as an independent NIH-funded basic investigator who share responsibility for creating the structured environment in which the intellectual rigor of laboratory investigation is enriched by the clinical perspective of surgical practice, thus providing both a broad and deep training experience that emphasizes translational potential and scholarly achievement. The training program centers on a supervised laboratory research project directed by a core or adjunct preceptor with oversight by the RFG co-directors. The research is supplemented by didactic coursework commensurate with the trainee's prior experience, and an organized program of seminars and research conferences that will enhance core knowledge base as well as skills in hypothesis formation, experimental design, grant preparation, and oral/written presentation of results. Extensive resources and core facilities are available for trainees, and special efforts are made to attract candidates from underrepresented minorities. Trainees receive instruction in the responsible conduct of research. At the completion of the program, surgeons-scientists will be strongly prepared for academic positions from which they will launch their investigative careers, while postdoctoral Ph.D. trainees should be competitive for entry-level independent funding.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK064581-04
Application #
7106412
Study Section
Special Emphasis Panel (ZDK1-GRB-6 (M2))
Program Officer
Densmore, Christine L
Project Start
2003-07-01
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
4
Fiscal Year
2006
Total Cost
$230,063
Indirect Cost
Name
University of Cincinnati
Department
Surgery
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Kulkarni, Rishikesh M; Kutcher, Louis W; Stuart, William D et al. (2012) Ron receptor-dependent gene regulation in a mouse model of endotoxin-induced acute liver failure. Hepatobiliary Pancreat Dis Int 11:383-92
Rowland, Kathryn J; Yao, Junjie; Wang, Lidai et al. (2012) Immediate alterations in intestinal oxygen saturation and blood flow after massive small bowel resection as measured by photoacoustic microscopy. J Pediatr Surg 47:1143-9
Thomas, Ryan M; Jaquish, Dawn V; French, Randall P et al. (2010) The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells. Pancreas 39:301-7
Logan-Collins, Jocelyn; Thomas, Ryan M; Yu, Peter et al. (2010) Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers. Cancer Res 70:1130-40
Martin, Colin A; Perrone, Erin E; Longshore, Shannon W et al. (2009) Intestinal resection induces angiogenesis within adapting intestinal villi. J Pediatr Surg 44:1077-82; discussion 1083
Thomas, R M; Kim, J; Revelo-Penafiel, M P et al. (2008) The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia. Gut 57:1555-60
Thomas, Ryan M; Toney, Kenya; Fenoglio-Preiser, Cecilia et al. (2007) The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression. Cancer Res 67:6075-82
Sheng, George; Bernabe, Kathryn Q; Guo, Jun et al. (2006) Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression. Gastroenterology 131:153-64
Guo, Jun; Sheng, George; Warner, Brad W (2005) Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells. J Biol Chem 280:35992-8
Yu, Wei; Datta, Anirban; Leroy, Pascale et al. (2005) Beta1-integrin orients epithelial polarity via Rac1 and laminin. Mol Biol Cell 16:433-45

Showing the most recent 10 out of 12 publications